Board of Directors
Director and Chief Executive Officer
Co-Founder of Cannsun South Africa and a Director of Propagation Services Canada the largest Cannabis facility under glass, and Former Managing Director of Natures Hemp Ltd in Canada, a company developing food-based Hemp products with the University of Manitoba and the Ontario Government. David has 20 plus years working with public and private companies in the natural resource and technology sector He has an extensive network of contacts and relationships throughout MENA, Europe, the Former Soviet Union (FSU), Asia and Africa and significant experience in mergers and acquisitions. He has been directly involved in over $500M of transactions in the last 10 years in Oil and Gas. He currently sits on the board of Volt Energy, a mineral exploration company in Canada; Northwest Mettech, a private tech company that supplies coating systems to the GE, Pratt and Whitney and others in the Aerospace industry. Mr. Parry also owns Mirage Door Systems in Canada which manufactures Screen Doors.
Director, CFO of Houwelings Group
Mr. Brocklesby is a CPA-CA currently holding the position of CFO for the Houwelings Group. He has also held roles with KPMG and Village Farms International Inc. where he gained assurance and invaluable experience in US/Canada taxation, finance and operation. Mr. Brocklesby has raised and restructured over $100m in senior and subordinate debt-related projects in Canada and the US. He is also responsible for intellectual property management, lender relationships and all legal matters. He is accountable for the Finance, Legal, IT, Risk Management, Food and Health Compliance and HR departments for the Group of Companies. He holds a B.Sc. in Agroecology and a Diploma in Accounting from UBC.
Professor at Pasteur Institute in plant-based medicine
Director, General Council
Stephen has over 20 years of experience as general counsel, legal advisor, director and project manager at corporates, funds, law firms including Deutsche Bank (UFG), Integra Group, Clifford Chance, Damac Properties and several funds. He has gathered international experience having worked in New York, Moscow, Dubai and now Geneva. His experience has been very diverse across sectors and territories including joint ventures and M&A, capital markets, debt and equity financing, infrastructure and funds. He has served on the boards of AIM, TSX and AIM listed entities as well as several funds.
Stephen graduated from Georgetown University Law School and is a member of the New York Bar. He speaks English and Russian and currently resides in Barcelona.
Rorisang has business interests in the petroleum and property development industries. He started his career at FNB Asset Management & Trust Services, where afterwards he worked for Citadel, eventually as an investment analyst. He has an extensive network from which he can draw relevant specialist and expertise to support current business interests or new project developments. He holds a Bcomm from (UNISA) the University of South Africa and JSE RPE Exams from (SAIFM) the South African Institute of Financial Markets.
Director, Chemist Co-Founder and Chief Medical Officer
Nickolas has a Chemistry degree from the University of Athens and a PhD in Chemical Engineering from Imperial College in London. He has received several special training courses including Commodity Trading from Wharton School (Univ. Of Pennsylvania), GMP guidelines for Pharmaceutical Industry from Leiden University and Design for masking flavors for the Pharmaceutical and Food industry from Hercules R&D center to name a few. He is a certified GMP by EMA auditor and has done numerous valuations and appraisals for the industry. He has been working in Greece and abroad in both technical and managerial positions. He has been R&D manager in National Starch and Chemicals, Commercial Director in Biotrek, Vice President and Commercial Director in Hellenic Register of Shipping, COO and IR Director in Alapis (the biggest Greek Pharma Co. at that time, raising more than €1.2B in deal roadshows), President and CEO for Provet (biggest animal healthcare company in the Balkans) among others. He has participated in more than 40 M&A’s and has set up pharmaceutical and other companies in more than 18 countries. He has also conducted several restructuring and financing projects creating a proven track record in these fields.